Immuneering Corp

Insider buying by Immuneering’s Chief People Officer signals confidence amid market volatility, with steady accumulation hinting at future growth potential.

Immuneering insider buying continues amid volatile shares, hinting at management confidence as the company advances its T‑cell therapy pipeline.